Regulation of the dopamine transporter - Addiction Research ...

DAT Regulation Schmitt & Reith
145. Davidson, C., A.J. Gow, T.H. Lee & E.H. Ellinwood.
2001. Methamphetamine neurotoxicity: necrotic and
apoptotic mechanisms and relevance to human abuse
and treatment. Brain Res. Brain Res. Rev. 36: 1–22
146. Hashimoto, K., H. Tsukada, S. Nishiyama, et al. 2004.
Protective effects of N-acetyl-l-cysteine on the reduction
of dopamine transporters in the striatum of
monkeys treated with methamphetamine. Neuropsychopharmacology
29: 2018–2023.
147. Miyazaki, I. & M. Asanuma. 2009. Approaches to prevent
dopamine quinone-induced neurotoxicity. Neurochem.
Res. 34: 698–706.
148. Harris, D.S., H. Boxenbaum, E.T. Everhart, et al.
2003. The bioavailability of intranasal and smoked
methamphetamine. Clin. Pharmacol. Ther. 74: 475–
486.
149. Dackis, C.A., K.M. Kampman, K.G. Lynch, et al.
A double-blind, placebo-controlled trial of modafinil
for cocaine dependence. Neuropsychopharmacology 30:
205–211.
150. Hart, C.L., M. Haney, S.K. Vosburg, et al. 2008. Smoked
cocaine self-administration is decreased by modafinil.
Neuropsychopharmacology 33: 761–768.
151. Zolkowska, D., R. Jain, R. Rothman, et al. 2009. Evidence
for the involvement of dopamine transporters in
behavioral stimulant effects of modafinil. J. Pharmacol.
Exp. Ther. 329: 738–746.
152. Rothman, R.B. & M.H. Baumann. 2006. Balance between
dopamine and serotonin release modulates behavioral
effects of amphetamine-type drugs. Ann. N. Y.
Acad. Sci. 1074: 245–260.
153. Rothman, R.B., B.E. Blough & M.H. Baumann. 2008.
Dopamine/serotonin releasers as medications for stimulant
addictions. Prog. Brain Res. 172: 385–406.
340 Ann. N.Y. Acad. Sci. 1187 (2010) 316–340 c○ 2010 New York Academy of Sciences.